Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, Mitra Tewes et al.|Journal of Clinical Oncology|2003Cited by 259
A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)J. Randolph Hecht, Christian Jacques, R.A. Wolff et al.|Journal of Clinical Oncology|2005Cited by 201